Gestational Diabetes
Conditions
Keywords
diabetes, pregnancy, myo-inositol
Brief summary
The aim of this study is to evaluate the efficacy of myo-inositol in preventing gestational diabetes in high risk pregnant women.
Interventions
DIETARY_SUPPLEMENTinositol + folic acid
2000 mg of inositol+200mcg of folic acid; 2 per diem
DRUGFolic Acid
Folic Acid 400mcg; 1 cp/die
Sponsors
AGUNCO Obstetrics and Gynecology Centre
Eligibility
Sex/Gender
FEMALE
Age
20 Years to 45 Years
Inclusion criteria
60 women in their first trimester of pregnancy affected by one or more of the following risk factors: * Glycemia levels \> 92 mg/dl * BMI \> 30 * At least a parent or a brother (or sister)affected by diabetes * Pre-existing pregnancy with gestational diabetes
Exclusion criteria
* Pregnant women affected by pregestational diabetes * Twin pregnancy * Patients affected by pre-existing diseases in pregnancy (diabetes excluded) * Patients affected by chronic disorders
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| OGTT | — | The diagnostic 75g oral glucose tolerance test (OGTT) is performed between 24 and 28 weeks of gestation. |
Secondary
| Measure | Time frame |
|---|---|
| Number of pregnant women with gestational diabetes | — |
| Number of pregnant women requiring insulin treatment | — |
| Weight gain at the end of pregnancy | — |
| Number of newborn infants whose weight is more than 4000 g | — |
| Number of newborn infants requiring Neonatal Intensive Care (NIC) | — |
Countries
Italy
Contacts
Primary ContactVittorio Unfer
Backup ContactGianfranco Carlomagno
Outcome results
None listed